UPDATE 1-FDA panel votes against Novartis drug for acute heart failureReuters UKNovartis filed for approval of the drug, serelaxin, based on a single study that showed that when given alongside standard treatment, it alleviated shortness of breath by s…
|
FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure …
Forbes The FDA’s Cardiovascular and Renal Drugs Advisory Committee voted unanimously (11-0) against approval of the biologics license application (BLA) for serelaxin (proposed trade name Reasanz). The novel drug from Novartis was intended to be used in … Novartis Heart Failure Drug Fails to Win FDA Panel BackingBloomberg FDA panel votes against Novartis drug for acute heart failureReuters FDA Panel Rejects Novartis Drug for Heart FailureWall Street Journal |
DrugWatch.com |
Study Links Actos to Development of Chronic Kidney Disease
DrugWatch.com Researchers have discovered a link between the diabetes drug Actos and an increased risk of chronic kidney disease. Doctors at Taiwan’s Kaohsiung Medical University found that diabetes patients who took Actos (pioglitazone) to help maintain blood … |
|
FDA panel votes against Novartis drug for acute heart failure
Reuters (Reuters) – A drug made by Novartis AG to treat acute heart failure should not be approved because there is insufficient evidence it improves symptoms, a panel of advisers to the U.S. Food and Drug Administration concluded on Thursday. The panel’s vote … |
|
AstraZeneca, Shenzehen University Collaborate on Chronic Kidney Disease …
Genetic Engineering News Scientists from Shenzhen University Health Science Center’s Nephrology and Urology Center will work in collaboration with teams from AstraZeneca’s Innovation Center China in Shanghai to undertake preclinical research focused on chronic kidney disease … |
The NationArtificial hearts may help patients survive until transplantMedical XpressThe largest single-center study of patients implanted with a total artificial heart finds the device may help patients in severe heart failure survive until they can re…
Research Study That Points to New Biological Mechanisms in Chronic Kidney …PR Web (press release)In light of a recent article in The Journal of Clinical Investigation, implicating mitochondrial oxidative stress in the progression of chronic kidney di…
New procedure a minimally-invasive alternative for heart failure patientsReuters IndiaMar. 26 – Czech doctors are pioneering a unique and minimally invasive heart modelation surgery, which is expected to significantly improve the quality of life for pa…
SKNVibes.comResidents receive free chronic kidney disease testingSKNVibes.comBasseterre, St. Kitts, March 26, 2014 (SKNIS): Residents of St. Kitts took full advantage of the opportunity to have free chronic kidney disease testing when the Caribbean Hea…
|
Pitt study examines benefits of depression treatment for heart failure patients
Phys.Org Can treating depression in patients with heart failure help them live longer? That’s one of the questions that University of Pittsburgh researchers hope to answer with a new five-year, $7.3 million grant from the National Heart, Lung, and Blood … |